{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:53:48Z","timestamp":1792598028990,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.amjms.2026.10.006","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:11:09Z","timestamp":1792595469000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome: A Practical Clinical Review"],"prefix":"10.1016","author":[{"given":"Licy L. Yanes","family":"Cardozo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar A.","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelina","family":"Basnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian G.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjms.2026.10.006_bib0001","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","article-title":"Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis","volume":"310","author":"Salari","year":"2024","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.amjms.2026.10.006_bib0002","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","article-title":"Polycystic ovary syndrome","volume":"10","author":"Stener-Victorin","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"10545","key":"10.1016\/j.amjms.2026.10.006_bib0003","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process","volume":"407","author":"Teede","year":"2026","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.amjms.2026.10.006_bib0004","first-page":"604","article-title":"Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome","volume":"102","author":"Gibson-Helm","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.amjms.2026.10.006_bib0005","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.amjms.2026.10.006_bib0006","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.amjms.2026.10.006_bib0007","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1038\/s41588-025-02393-x","article-title":"Multi-ancestry genome-wide association analyses of polycystic ovary syndrome","volume":"57","author":"Zhao","year":"2025","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.amjms.2026.10.006_bib0008","article-title":"Hirsutism, Normal Androgens and Diagnosis of PCOS","volume":"12","author":"Spritzer","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"Suppl 4","key":"10.1016\/j.amjms.2026.10.006_bib0009","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"77","author":"Burger","year":"2002","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.amjms.2026.10.006_bib0010","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.fertnstert.2008.12.138","article-title":"Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria","volume":"93","author":"Huang","year":"2010","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.amjms.2026.10.006_bib0011","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.amjms.2026.10.006_bib0012","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2265.2012.04486.x","article-title":"Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism","volume":"78","author":"Caronia","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.amjms.2026.10.006_bib0013","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O'Reilly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.amjms.2026.10.006_bib0014","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/humrep\/dead156","article-title":"Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndromedagger","volume":"38","author":"Teede","year":"2023","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.amjms.2026.10.006_bib0015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.fertnstert.2024.05.163","article-title":"Anti-mullerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis","volume":"122","author":"Van der Ham","year":"2024","journal-title":"Fertil Steril"},{"key":"10.1016\/j.amjms.2026.10.006_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-026-01261-w","article-title":"Polyendocrine metabolic ovarian syndrome in pregnancy: pathophysiology and outcomes","author":"Teede","year":"2026","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.amjms.2026.10.006_bib0017","doi-asserted-by":"crossref","first-page":"d6309","DOI":"10.1136\/bmj.d6309","article-title":"Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study","volume":"343","author":"Roos","year":"2011","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.amjms.2026.10.006_bib0018","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/humrep\/deac210","article-title":"Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts","volume":"37","author":"Farland","year":"2022","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.amjms.2026.10.006_bib0019","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1038\/s41467-024-49749-1","article-title":"Systematic review and meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"15","author":"Bahri Khomami","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.amjms.2026.10.006_bib0020","article-title":"Insulin Resistance is a Risk Factor for Early Miscarriage and Macrosomia in Patients With Polycystic Ovary Syndrome From the First Embryo Transfer Cycle: A Retrospective Cohort Study","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.amjms.2026.10.006_bib0021","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.rbmo.2022.02.007","article-title":"Association between obesity in women with polycystic ovary syndrome and adverse obstetric outcomes","volume":"45","author":"Peeva","year":"2022","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"10.1016\/j.amjms.2026.10.006_bib0022","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/aje\/kwae061","article-title":"Polycystic ovary syndrome and endometrial cancer risk: results from a nationwide cohort study","volume":"193","author":"Frandsen","year":"2024","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.amjms.2026.10.006_bib0023","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.amjms.2026.10.006_bib0024","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"9","key":"10.1016\/j.amjms.2026.10.006_bib0025","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.amjms.2026.10.006_bib0026","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1210\/jc.2017-01354","article-title":"Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome","volume":"102","author":"Rubin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.amjms.2026.10.006_bib0027","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"issue":"12","key":"10.1016\/j.amjms.2026.10.006_bib0028","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa674","article-title":"Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline","volume":"105","author":"Newman","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.amjms.2026.10.006_bib0029","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod Health"},{"issue":"1","key":"10.1016\/j.amjms.2026.10.006_bib0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11325-019-01835-1","article-title":"The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Kahal","year":"2020","journal-title":"Sleep Breath"},{"issue":"9","key":"10.1016\/j.amjms.2026.10.006_bib0031","doi-asserted-by":"crossref","first-page":"e3369","DOI":"10.1210\/clinem\/dgab392","article-title":"Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study","volume":"106","author":"Berni","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"10.1016\/j.amjms.2026.10.006_bib0032","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033572","article-title":"2023 International Evidence-Based Polycystic Ovary Syndrome Guideline Update: Insights From a Systematic Review and Meta-Analysis on Elevated Clinical Cardiovascular Disease in Polycystic Ovary Syndrome","volume":"13","author":"Tay","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.amjms.2026.10.006_bib0033","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.amjms.2026.10.006_bib0034","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2014.08.001","article-title":"Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?","volume":"102","author":"Daan","year":"2014","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.amjms.2026.10.006_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12958-020-00576-1","article-title":"Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"18","author":"Amiri","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"10.1016\/j.amjms.2026.10.006_bib0036","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/jc.2018-00570","article-title":"Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study","volume":"104","author":"Ollila","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.amjms.2026.10.006_bib0037","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s10995-025-04155-x","article-title":"Hypertension and Polycystic Ovary Syndrome Among Women in a Nationwide Electronic Health Records Dataset in the United States","volume":"29","author":"He","year":"2025","journal-title":"Matern Child Health J"},{"issue":"6","key":"10.1016\/j.amjms.2026.10.006_bib0038","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1210\/clinem\/dgab134","article-title":"Incidence and Predictors of Hypertension in a Cohort of Australian Women With and Without Polycystic Ovary Syndrome","volume":"106","author":"Joham","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.amjms.2026.10.006_bib0039","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.fertnstert.2018.11.034","article-title":"ACC\/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome","volume":"111","author":"Marchesan","year":"2019","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.amjms.2026.10.006_bib0040","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/10641963.2020.1772815","article-title":"Increased masked hypertension prevalence in patients with polycystic ovary syndrome (PCOS)","volume":"42","author":"Ozkan","year":"2020","journal-title":"Clin Exp Hypertens"},{"issue":"2","key":"10.1016\/j.amjms.2026.10.006_bib0041","doi-asserted-by":"crossref","first-page":"H232","DOI":"10.1152\/ajpheart.00164.2023","article-title":"Testosterone-associated blood pressure dysregulation in women with androgen excess polycystic ovary syndrome","volume":"325","author":"Stone","year":"2023","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"10.1016\/j.amjms.2026.10.006_bib0042","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.amjms.2026.10.006_bib0043","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1210\/jc.2013-2007","article-title":"Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome","volume":"99","author":"Joham","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.amjms.2026.10.006_bib0044","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/obe.2007.0019","article-title":"Obesity and Polycystic Ovary Syndrome","volume":"3","author":"Sam","year":"2007","journal-title":"Obes Manag"},{"key":"10.1016\/j.amjms.2026.10.006_bib0045","article-title":"Bariatric surgery as a treatment of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Mirghani","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"26","key":"10.1016\/j.amjms.2026.10.006_bib0046","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3748\/wjg.v20.i26.8351","article-title":"Nonalcoholic fatty liver disease and polycystic ovary syndrome","volume":"20","author":"Vassilatou","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.amjms.2026.10.006_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1532519","article-title":"Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Abdul Jafar","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.amjms.2026.10.006_bib0048","article-title":"Clinical characteristics and pregnancy outcomes in polycystic ovary syndrome complicated by obstructive sleep apnea: a correlative study","volume":"13","author":"Li","year":"2026","journal-title":"Front Med (Lausanne)"},{"issue":"13","key":"10.1016\/j.amjms.2026.10.006_bib0049","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjms.2026.10.006_bib0050","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"32","author":"Cooney","year":"2017","journal-title":"Hum Reprod"},{"issue":"7","key":"10.1016\/j.amjms.2026.10.006_bib0051","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaf091","article-title":"Androgen Receptor PROTAC ARV-110 Ameliorates Metabolic Complications in a Mouse Model of Polycystic Ovary Syndrome","volume":"166","author":"Basnet","year":"2025","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.amjms.2026.10.006_bib0052","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaf173","article-title":"Adiponectin Receptor Agonist AdipoRon Ameliorates the Metabolic Complications in a Hyperandrogenic Rat Model of PCOS","volume":"167","author":"Abdelhameed","year":"2025","journal-title":"Endocrinology"},{"issue":"19","key":"10.1016\/j.amjms.2026.10.006_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910575","article-title":"Inositols: From Established Knowledge to Novel Approaches","volume":"22","author":"Dinicola","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.amjms.2026.10.006_bib0054","doi-asserted-by":"crossref","first-page":"E237","DOI":"10.1152\/ajpendo.00162.2019","article-title":"The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment","volume":"318","author":"Cabrera-Cruz","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.amjms.2026.10.006_bib0055","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0006-291X(02)00313-3","article-title":"Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls","volume":"293","author":"Sun","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.amjms.2026.10.006_bib0056","first-page":"47","article-title":"D-chiro-inositol\u2013its functional role in insulin action and its deficit in insulin resistance","volume":"3","author":"Larner","year":"2002","journal-title":"Int J Exp Diabetes Res"},{"issue":"1","key":"10.1016\/j.amjms.2026.10.006_bib0057","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12958-023-01055-z","article-title":"Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"21","author":"Greff","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"10.1016\/j.amjms.2026.10.006_bib0058","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1210\/clinem\/dgad762","article-title":"Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines","volume":"109","author":"Fitz","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.amjms.2026.10.006_bib0059","doi-asserted-by":"crossref","first-page":"283","DOI":"10.33549\/physiolres.933366","article-title":"Distinct response of fat and gastrointestinal tissue to glucose in gestational diabetes mellitus and polycystic ovary syndrome","volume":"66","author":"Vejrazkova","year":"2017","journal-title":"Physiol Res"},{"key":"10.1016\/j.amjms.2026.10.006_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109555","article-title":"Glucagon-like peptide-1 receptor expression and its functions are regulated by androgen","volume":"120","author":"Zhu","year":"2019","journal-title":"Biomed Pharmacother"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926003976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962926003976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:11:16Z","timestamp":1792595476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962926003976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":60,"alternative-id":["S0002962926003976"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2026.10.006","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome: A Practical Clinical Review","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2026.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}